Effects of Short-term Fasting on Tolerance to Chemotherapy
NCT01304251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2016-01-12
Summary
The purpose of this study is to determine the effect of short-term fasting on tolerance to adjuvant chemotherapy in breast cancer patients
Conditions
Interventions
- OTHER
-
Short-term fasting
Short-term fasting, i.e. 24 hours before and 24 hours after administration of chemotherapy
- OTHER
-
Healthy nutrition
Eating according to the current guidelines for healthy nutrition as from 24 hours before until 24 hours after the beginning of administration of chemotherapy. Dietary instructions will be given by a dietician and actual food intake will be recorded in a journal.
Sponsors & Collaborators
-
Leiden University Medical Center
lead OTHER
Principal Investigators
-
Hanno Pijl, MD PhD · Leiden University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2013-04-30
- Completion
- 2015-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Electronic Patient Reporting of Side Effects to Chemotherapy: A Cluster Randomized Controlled Trial
NCT02996201 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Impact of Adjuvant Chemotherapy on Functional Status, Comorbidity and Quality of Life
NCT01030250 ·Status: ACTIVE_NOT_RECRUITING
-
Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients
NCT06273800 ·Status: RECRUITING ·Phase: NA
-
Exploratory Study Therapeutic Fasting Reduce Physical Limitations, Quality of Life During Aromatase Inhibitor Therapy
NCT06172088 ·Status: COMPLETED ·Phase: NA
-
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment
NCT03625635 ·Status: UNKNOWN ·Phase: NA
-
Antioxidant Supplements, Genetics and Chemotherapy Outcomes
NCT03413761 ·Status: COMPLETED
-
Evaluation of Eating Habits and Dysgeusia During Chemotherapy Treatment in Patients Affected by Breast Cancer
NCT03210441 ·Status: UNKNOWN
-
Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
NCT04268134 ·Status: COMPLETED ·Phase: PHASE2
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
NCT06106477 ·Status: RECRUITING ·Phase: NA
-
Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
NCT00003099 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate or Delayed Naturopathic Medicine in Combination With Neo-Adjuvant Chemotherapy for Breast Cancer
NCT02486796 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children
NCT00458588 ·Status: COMPLETED
-
Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer
NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3
-
Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer
NCT03946579 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Sexual Quality of Life for Breast Cancer
NCT04200001 ·Status: COMPLETED
-
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
NCT00403182 ·Status: WITHDRAWN ·Phase: PHASE3
-
Supervised Aerobic Training During or After Chemotherapy for Operable Breast Cancer
NCT01943695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer
NCT04272801 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
NCT00022516 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Dose Monitoring (TDM) of Tamoxifen
NCT05133674 ·Status: UNKNOWN ·Phase: PHASE2
-
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
NCT03837496 ·Status: COMPLETED ·Phase: NA
-
Tamoxifen in Treating Women With High-Risk Breast Cancer
NCT00002542 ·Status: COMPLETED ·Phase: PHASE3
-
LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer
NCT06831955 ·Status: RECRUITING ·Phase: PHASE2